Table 3.
Demographic and Clinical Characteristics According to the Occurrence or not VTE During Follow-up
| VTE (n = 55) | No VTE (n = 936) | p | p* | |
| Age, years | 75.7 (0.9) | 73.4 (0.2) | .02 | |
| Sex, females | 45 (81.8) | 505 (54.0) | <.001 | |
| Stroke | 8 (14.6) | 83 (8.9) | .16 | .13 |
| Diabetes | 16 (29.1) | 162 (17.3) | .03 | .03 |
| Congestive heart failure | 25 (45.5) | 363 (38.8) | .32 | .60 |
| Myocardial infarction | 8 (14.6) | 99 (10.6) | .36 | .29 |
| Cancer | 7 (12.7) | 101 (10.8) | .66 | .84 |
| History of hip/femur fracture | 9 (16.4) | 38 (4.1) | <.001 | .003 |
| History of VTE at baseline | 27 (49.1) | 63 (6.7) | <.001 | <.001 |
| Non obese with normal strength | 16 (29.1) | 374 (38.3) | .001† | .001† |
| Obesity with normal strength | 14 (25.5) | 140 (14.9) | ||
| Non obese with poor muscle strength | 13 (23.6) | 348 (37.2) | ||
| Obesity with poor muscle strength | 12 (21.8) | 90 (9.6) | ||
| Hospitalization | 31 (56.4) | 350 (37.4) | .004 | .003 |
| Short physical performance battery (0-12) | 9.1 (0.4) | 10.4 (0.1) | <.001 | .008 |
| FICSIT balance score | 19.2 (0.6) | 21.1 (0.1) | <.001 | .008 |
| Muscle power (dominant) leg | 79.1 (7.1) | 106.3 (2.2) | .003 | .80 |
| Muscle strength knee extension, kg | 14.1 (0.7) | 16.4 (0.2) | .006 | .83 |
| Use of anticoagulants | 11 (20.0) | 36 (3.9) | <.001 | <.001 |
Notes: Data are reported as frequencies (percentages) for dichotomous or categorical variables and as mean (SE) for continuous variables. *p values adjusted for age and sex; †for trend p value. VTE = venous thromboembolism; FICSIT = Frailty and Injuries: Cooperative Studies of Intervention Techniques.